Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04447716
Title An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Thomas Jefferson University

marginal zone B-cell lymphoma

follicular lymphoma


Lenalidomide + Rituximab Hyaluronidase + Venetoclax

Lenalidomide + Rituximab + Venetoclax

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.